IL6 and COVID-19: Reports suggests that the hyperinflammation seen in severe COVID-19 may be driven by considerable levels of C-reactive protein (CRP) and Interleukin (IL)-6, resembling “cytokine storms” seen in other comparable conditions such as during CAR T cell therapy19–21.